It has not been licensed for use in the United States , but it was approved this year in Europe and Australia . CDC preparing to recommend patients get group B vaccine . That recommendation is awaiting final approval from a review board . The meningitis group B vaccine is not approved in the U.S. Novartis spokeswoman : Necessary doses would take up to two months to arrive .
CDC preparing to recommend patients get group B vaccine . That recommendation is awaiting final approval from a review board . The meningitis group B vaccine is not approved in the U.S. Novartis spokeswoman : Necessary doses would take up to two months to arrive .